Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Bavarian Nordic — April 2020

Planlagt Fastgjort Låst Flyttet Bavarian Nordic
278 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • F Offline
    F Offline
    Farmaceuten
    wrote on sidst redigeret af
    #154

    At de skal kunne virke som CMO (Contract Manufacturing Orginazation). Så de behøver ikke at lave selve det aktive stof for at skulle kunne hhjælpe med at fylde corona vacciner. Der er ikke SÅ mange i verden der kan fylde vacciner da vacciner kan have meget anderledes krav til sikkerhed (nogen er stadig levende osv)

    1 Reply Last reply
    0
    • exitnuE Offline
      exitnuE Offline
      exitnu
      wrote on sidst redigeret af
      #155

      Zealand Pharma presents positive clinical and health economic outcome data with use of regular human insulin delivered by the V-Go in adults with type 2 diabetes.

      1 Reply Last reply
      0
      • exitnuE Offline
        exitnuE Offline
        exitnu
        wrote on sidst redigeret af
        #156

        Link: https://ml-eu.globenewswire.com/Resource/Download/c0db1193-8508-4f83-8361-a5d86eff5d98

        1 Reply Last reply
        0
        • D Offline
          D Offline
          DSDK
          wrote on sidst redigeret af
          #157

          Skal BAVA tilbage til i 120'erne over de kommende dage ? Nogle bud ?

          1 Reply Last reply
          0
          • exitnuE Offline
            exitnuE Offline
            exitnu
            wrote on sidst redigeret af
            #158

            “With the rising cost of healthcare, patients and providers continue to look for effective and affordable ways to treat diabetes” commented Adam Steensberg, Executive Vice President of Research and Development, and Chief Medical Officer at Zealand Pharma.

            1 Reply Last reply
            0
            • exitnuE Offline
              exitnuE Offline
              exitnu
              wrote on sidst redigeret af
              #159

              “These results show that V-Go may allow diabetes patients to achieve their treatment goals with more affordable regular human insulin. We hope to make this treatment solution available to benefit patients as soon as possible.”

              1 Reply Last reply
              0
              • H Offline
                H Offline
                Hfencker
                wrote on sidst redigeret af
                #160

                Zealand: https://ml-eu.globenewswire.com/Resource/Download/c0db1193-8508-4f83-8361-a5d86eff5d98

                1 Reply Last reply
                0
                • exitnuE Offline
                  exitnuE Offline
                  exitnu
                  wrote on sidst redigeret af
                  #161

                  Zealand Pharma opnår positive testresultater med nyindkøbt insulinpumpe

                  Efter en 14-dages test har Zealand Pharma opnået positive kliniske og økonomiske resultater med insulin-enheden V-Go. Firmaet håber nu på at udbydde enheden snarest muligt.
                  https://medwatch.dk/Medicinal___Biotek/article12078044.ece

                  1 Reply Last reply
                  0
                  • B Offline
                    B Offline
                    bibob
                    wrote on sidst redigeret af
                    #162

                    @exitnu. Jeg synes nu Hfencker's link 18.29 var bedre. 😉

                    1 Reply Last reply
                    0
                    • exitnuE Offline
                      exitnuE Offline
                      exitnu
                      wrote on sidst redigeret af
                      #163

                      Hvad med linket 17:57 🙂

                      1 Reply Last reply
                      0
                      • B Offline
                        B Offline
                        bibob
                        wrote on sidst redigeret af
                        #164

                        Det er også ok. :-). Men hvorfor så gentagelsen. 😉

                        1 Reply Last reply
                        0
                        • K Offline
                          K Offline
                          kkjoel
                          wrote on sidst redigeret af
                          #165

                          Og, ikke unormalt, får Medwatch galt fat i nyheden: det er efter 14 UGERS test, ikke 14 dage! Måske bare en tanketorsk/slåfejl, men at skrive dette uden bare at blive strejfet af tanken, at 14 dage må være for kort tid...

                          1 Reply Last reply
                          0
                          • K Offline
                            K Offline
                            kkjoel
                            wrote on sidst redigeret af
                            #166

                            Og, noget mystisk: i pressemedd. refererer ZELA til dette 14-ugers forsøg.. men linker som dokumentation/henvisning til en clinicaltrial, der blev afsluttet i maj, 2014!

                            1 Reply Last reply
                            0
                            • K Offline
                              K Offline
                              kkjoel
                              wrote on sidst redigeret af
                              #167

                              "This 14-week randomized, non-inferiority trial was conducted in a real-world practice setting under usual standard of care across three centers in the United States. Patients administering U-100 RAI analogs with V-Go® were randomly assigned to either continue RAI delivery by V-Go® or switch to U-100 RHI."

                              1 Reply Last reply
                              0
                              • K Offline
                                K Offline
                                kkjoel
                                wrote on sidst redigeret af
                                #168

                                "The primary end-point was change in overall blood glucose levels (HbA1c), assessments of safety measures and insulin costs* were evaluated as secondary endpoints. For more information, visit https://www.clinicaltrials.gov/ct2/show/NCT01326598."

                                1 Reply Last reply
                                0
                                • exitnuE Offline
                                  exitnuE Offline
                                  exitnu
                                  wrote on sidst redigeret af
                                  #169

                                  Medwatch har mange gange deres eget skriv/vinkel på en Zealand Pharma nyhed. Derfor.

                                  1 Reply Last reply
                                  0
                                  • K Offline
                                    K Offline
                                    kkjoel
                                    wrote on sidst redigeret af
                                    #170

                                    Ha ha

                                    1 Reply Last reply
                                    0
                                    • exitnuE Offline
                                      exitnuE Offline
                                      exitnu
                                      wrote on sidst redigeret af
                                      #171

                                      I øvrigt brugte jeg nok næsten en time i går i selskab med søgetermen "Insulet vs Tandem" 🙂

                                      1 Reply Last reply
                                      0
                                      • K Offline
                                        K Offline
                                        kkjoel
                                        wrote on sidst redigeret af
                                        #172

                                        I øvrigt: 1000, tusind tak til BioBio og Farmaceuten (og andre) for at I tager jer tid til at danne os ikke-fagfolk ud på vacciner, virus, osv. (fx produktionen af dem)!!

                                        1 Reply Last reply
                                        0
                                        • K Offline
                                          K Offline
                                          kkjoel
                                          wrote on sidst redigeret af
                                          #173

                                          Jeg har, naturligvis, et par opfølgende spørgsmål.. de kommer snarest 😉

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger